Ligand ID: VOG Drugbank ID: DB04878(Voglibose) Indication:For the treatment of diabetes. It is specifically used for lowering post-prandial blood glucose levels thereby reducing the risk of macrovascular complications. |
DrReposER ID / Desc. | Hit PDBID |
Hit Macromolecule |
Res. Matches |
View | Interface | RMSD | Seq. Identity (%) |
HETATM | Dock | |
---|---|---|---|---|---|---|---|---|---|---|
![]() | 6C9Z_B_VOGB701_0 (GLYCOSYL HYDROLASE,FAMILY 31) | 5xlr | SPIKE GLYCOPROTEIN (SARSr-CoV) | 5 / 12 | ASP C 727ASP C 719MET C 722ARG A 306PHE A 305 | 1.76A | 20.47 | ASP C 727 ( 0.5A)ASP C 719 ( 0.6A)MET C 722 ( 0.0A)ARG A 306 ( 0.6A)PHE A 305 ( 1.3A) | ||
![]() | 6C9X_A_VOGA701_0 (GLYCOSYL HYDROLASE,FAMILY 31) | 5xlr | SPIKE GLYCOPROTEIN (SARSr-CoV) | 5 / 12 | ASP C 727ASP C 719MET C 722ARG A 306PHE A 305 | 1.80A | 20.38 | ASP C 727 ( 0.5A)ASP C 719 ( 0.6A)MET C 722 ( 0.0A)ARG A 306 ( 0.6A)PHE A 305 ( 1.3A) | ||
![]() | 6C9Z_B_VOGB701_0 (GLYCOSYL HYDROLASE,FAMILY 31) | 6crv | SPIKEGLYCOPROTEIN,FIBRITIN (SARSr-CoV) | 5 / 12 | ASP C 727ASP C 719MET C 722ARG B 306PHE B 305 | 1.68A | 20.53 | None |